Side-by-side comparison of AI visibility scores, market position, and capabilities
Colombia YC W23 dollar neobank with 200K+ users and $80M+ transactions; $4.2M Goodwater/Taisu/YC-backed USDC-powered peso-to-dollar banking competing with Nubank for LATAM consumer currency protection and dollar savings.
Littio is a Bogotá, Colombia-based dollar-denominated neobank — backed by Y Combinator (W23) with $4.2 million in total funding from Goodwater Capital, Taisu Ventures, and Y Combinator — providing Colombian consumers and Latin American users with dollar bank accounts, USDC-powered dollar savings, and international payment capabilities that protect savings from Colombian peso devaluation and enable seamless USD transactions. Having grown to 200,000+ Colombian users processing $80 million+ in transactions, Littio offers dollar accounts accessible via mobile app, allowing users to hold, send, and receive dollars at a time when Colombian peso volatility (the COP depreciated 20%+ against the USD between 2021 and 2024) makes dollar-denominated savings a critical wealth preservation strategy.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.